SCHEMBL4068814

SCHEMBL4068814

Brc1cncc2cc3ccccc3cc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HASPIN Q8TF76 2/20 0.39
CCNT1 O60563 1/20 0.39
PIM1 P11309 1/20 0.39
CDK9 P50750 1/20 0.39
CYP2A6 P11509 2/20 0.37
CYP11B1 P15538 3/20 0.35
CYP11B2 P19099 3/20 0.35
CYP1A2 P05177 2/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2B6 P20813 1/20 0.35
CYP2C19 P33261 1/20 0.35
PDE10A Q9Y233 2/20 0.35
ALDH1A1 P00352 3/20 0.34
GLA P06280 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
ACHE P22303 1/20 0.34
PRKCZ Q05513 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL111247 0.80 PRKCZ (0.46) CYP2A6CYP11B1CYP11B2CYP1A2CYP3A4
SCHEMBL29375416 0.80 PRKCZ (0.46) CYP2A6CYP11B1CYP11B2CYP1A2CYP3A4
Iodide SCHEMBL27879062 0.78 PRKCZ (0.44) CYP2A6CYP11B1CYP11B2CYP1A2CYP3A4
SCHEMBL24622042 0.75 CYP1A2 (0.42) CYP2A6CYP11B1CYP11B2CYP1A2CYP3A4
SCHEMBL6993140 0.73 CYP11B1 (0.44) CYP11B1CYP11B2ALDH1A1MAPTHPGD
SCHEMBL2407961 0.73 ALDH1A1 (0.45) CYP2A6CYP1A2CYP3A4CYP2C19ALDH1A1
SCHEMBL29388401 0.73 ALDH1A1 (0.45) CYP2A6CYP1A2CYP3A4CYP2C19ALDH1A1
SCHEMBL30099343 0.72 NOS1 (0.39) HASPINCCNT1PIM1CDK9CYP2A6
SCHEMBL5497704 0.72 NOS1 (0.39) HASPINCCNT1PIM1CDK9CYP2A6
SCHEMBL27191796 0.72 CYP11B1 (0.35) CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7501435-B2 Inhibitors of checkpoint kinases MERCK & CO., INC. (US) 2009-03-10 US disclosed
US-7501435-B2 Inhibitors of checkpoint kinases MERCK & CO., INC. (US) 2009-03-10 US disclosed
US-7501435-B2 Inhibitors of checkpoint kinases MERCK & CO., INC. (US) 2009-03-10 US disclosed
EP-2013212-A1 TRIAZOLOQUINAZOLINONE DERIVATIVES AS INHIBITORS OF CHECKPOINT KINASES Merck & Co., Inc. (US) 2009-01-14 EP disclosed
WO-2007127138-A1 TRIAZOLOQUINAZOLINONE DERIVATIVES AS INHIBITORS OF CHECKPOINT KINASES MERCK & CO., INC. (US) 2007-11-08 WO disclosed
WO-2007127138-A1 TRIAZOLOQUINAZOLINONE DERIVATIVES AS INHIBITORS OF CHECKPOINT KINASES MERCK & CO., INC. (US) 2007-11-08 WO disclosed
US-20070254879-A1 Inhibitors of checkpoint kinases MERCK SHARP & DOHME CORP. 2007-11-01 US disclosed
US-20070254879-A1 Inhibitors of checkpoint kinases MERCK SHARP & DOHME CORP. 2007-11-01 US disclosed
US-20070254879-A1 Inhibitors of checkpoint kinases MERCK SHARP & DOHME CORP. 2007-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070254879-A1 Inhibitors of checkpoint kinases CHEK1, CHEK2, PLK1 HASPIN 848/4885CCNT1 256/4885PIM1 1009/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.